Thursday, 3 August 2017

No Cure in Sight for Teva

Don’t be fooled by the low valuation. Teva Pharmaceutical Industries is a dangerous stock to own.

from WSJ.com: Markets http://ift.tt/2u7VmIg
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)